KLK3 and benign prostatic hyperplasia: Our study revealed that the urinary ITGAV test can clearly distinguish between PCa and BPH and predict the benign diagnosis in 56% cases with the serum PSA level greater than 4 ng/ml, suggesting its use to reduce unnecessary biopsies in case of PCa diagnosis.